Justin C Yang

I study complex and co-occurring mental health needs: people with severe mental illness who also use drugs or alcohol or need social care, and neurodivergent children whose needs cross health and education. These needs span services that each see only part of the picture, and that is where they go unmet.

Whether someone with psychosis who uses drugs is treated by one service or passed between two, or whether a school recognises a child's autism, can shape what follows. To see these needs whole, I bring sources together: linked records from the NHS, addiction treatment services, and schools, clinical text, and national surveys, triangulated to show where needs go unmet and where services and policy could act.

This is the work of MINDSET (Multimodal Inference and Data Science for Epidemiology and Treatment), my research group in the UCL Division of Psychiatry, with two postdoctoral research fellows and two doctoral students (Team).

At a glance

Position
Psychiatric epidemiologist and Senior Research Fellow, UCL Division of Psychiatry
Funding as principal investigator
£562k from three competitive awards since 2024, from UKRI, ESRC, and NIHR (Funding)
Collaborative awards
£1.9m across four awards as co-investigator or work package lead
Policy
Work I have co-authored is cited in about 35 policy documents, including OECD and WHO reports
National roles
Associate Editor, Addiction; Expert Member, Health Research Authority Confidentiality Advisory Group; Deputy Lead, North London NHS Foundation Trust research database (About)

Research

Three areas, in order of my current funded work. Research has the detail.

WISDOMUKRI, 2026–29Ward observationNIHR, 2024–27Health and social care dataNIHR, from 2027

Severe mental illness

Treatment, harms, and unmet need in hospital and in the community, including the social care support that NHS records miss.

Key finding: antipsychotic polypharmacy was associated with endocrine and metabolic adverse drug reactions among 13,391 patients (Psychological Medicine, 2022; joint first author).

UNITEDNIHR, 2026Stigma in servicesNIHR, 2026

Addictions

Who reaches treatment for drug and alcohol problems, particularly people who also have a mental illness, and what stands in the way.

Key findings: cost was the barrier most often reported by US adults with unmet need for mental health treatment, and provision of opioid agonist treatment varied by region, organisation, and payment (2019 and 2020; first author).

HOPE-SENADR UK, 2024–26

Neurodevelopmental conditions

Which autistic and other neurodivergent children are recognised and supported by schools and health services, and what follows for attendance, exclusion, and hospital admission.

Key finding: recorded autism incidence among more than 7 million pupils in England differed sharply between social and ethnic groups and between areas (Lancet Child & Adolescent Health, 2022; joint first author). A 2026 OECD report cites it.

Working together

I collaborate with academic groups, NHS trusts, treatment providers, and people with lived experience, and I welcome enquiries about research partnerships and doctoral supervision. Get in touch.